Matthew Maenner is surveillance team lead for the National Center on Birth Defects and Developmental Disabilities at the U.S. Centers for Disease Control and Prevention.
Matthew Maenner
Surveillance team lead
National Center on Birth Defects and Developmental Disabilities
From this contributor
Q&A with Matthew Maenner: Estimating autism prevalence quickly
A new method to track autism prevalence in 11 U.S. states is twice as fast as the old approach — and yields similar results.
Q&A with Matthew Maenner: Estimating autism prevalence quickly
Explore more from The Transmitter
Commentary: Citation graphs may underestimate neuroscience’s influence on AI
An alternative, albeit less quantitative, way to trace this history is through the people who carried ideas between the fields.
Commentary: Citation graphs may underestimate neuroscience’s influence on AI
An alternative, albeit less quantitative, way to trace this history is through the people who carried ideas between the fields.
Commentary: The rising absolute number of neuro-inspired AI papers represents a substantial footprint
Many of the design choices present in the current generation of artificial-intelligence tools parallel purported properties of the brain.
Commentary: The rising absolute number of neuro-inspired AI papers represents a substantial footprint
Many of the design choices present in the current generation of artificial-intelligence tools parallel purported properties of the brain.
Examining the bridge between neuroscience and AI
A citation analysis reveals that the connection between the two fields is real and gaining momentum. But it’s also narrow and tool-heavy; we need to find ways to widen it.
Examining the bridge between neuroscience and AI
A citation analysis reveals that the connection between the two fields is real and gaining momentum. But it’s also narrow and tool-heavy; we need to find ways to widen it.